Holen Sie sich die Stockscreener-App
2.25
1.75%
-0.04
Vorhandelsmarkt:
2.29
0.04
+1.78%
Finanzdaten der Acumen Pharmaceuticals Inc-Aktie (ABOS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
36.50%
26.51
|
41.75 | 30.37 | 39.60 | 32.27 |
| Operating Income/Loss |
36.50%
-26.51
|
-41.75 | -30.37 | -39.60 | -32.27 |
| Nonoperating Income/Loss |
92.25%
0.062
|
0.80 | 1.574 | 2.443 | 2.50 |
| Income/Loss From Continuing Operations Before Tax |
35.41%
-26.45
|
-40.95 | -28.80 | -37.15 | -29.77 |
| Income/Loss From Continuing Operations After Tax |
35.41%
-26.45
|
-40.95 | -28.80 | -37.15 | -29.77 |
|
Net Income/Loss
|
35.41%
-26.45
|
-40.95 | -28.80 | -37.15 | -29.77 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.00%
60.57
|
60.57 | 60.53 | 0.0224 | 60.08 |
| Diluted Average Shares |
0.00%
60.57
|
60.57 | 60.53 | 0.0224 | 60.08 |
| Basic Earnings Per Share |
35.29%
-0.44
|
-0.68 | -0.48 | -0.62 | -0.50 |
| Diluted Earnings Per Share |
35.29%
-0.44
|
-0.68 | -0.48 | -0.62 | -0.50 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.60%
0.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):